Mark C. Genovese
- Rheumatology top 0.01%
- Immunology top 0.1%
- Hematology top 0.05%
- Genetics top 0.1%
- Oncology top 0.5%
- Co-authors
- Edward KeystoneRoy FleischmannLarry W. MorelandMichael SchiffStanley CohenJoan M. BathonEric J. KunkelEugene C. Butcher
- Topics
- Rheumatoid Arthritis Research and Therapies (210 papers)Chronic Lymphocytic Leukemia Research (112 papers)Autoimmune and Inflammatory Disorders Research (88 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Mark C. Genovese
311 papers receiving 22.0k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Rheumatology 14.1k
- Immunology 8.5k
- Hematology 6.5k
- Genetics 3.5k
- Oncology 3.4k
Countries citing papers authored by Mark C. Genovese
This map shows the geographic impact of Mark C. Genovese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Genovese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Genovese more than expected).
Fields of papers citing papers by Mark C. Genovese
This network shows the impact of papers produced by Mark C. Genovese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Genovese. The network helps show where Mark C. Genovese may publish in the future.
Co-authorship network of co-authors of Mark C. Genovese
This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Genovese. A scholar is included among the top collaborators of Mark C. Genovese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Genovese. Mark C. Genovese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 2 | |
| 3 | 14 | |
| 4 | 10 | |
| 5 | 9 | |
| 6 | 85 | |
| 7 | 18 | |
| 8 | Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response. | 6 |
| 9 | 27 | |
| 10 | Prolonged Exposure to Subcutaneous and Intravenous Abatacept in Patients with Rheumatoid Arthritis does not Affect Rates of Infection, Malignancy and Autoimmune Events: Results from Pooled Clinical Trial Data | 1 |
| 11 | Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis | 5 |
| 12 | Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs | 13 |
| 13 | Safety profile of subcutaneous abatacept focusing On clinically relevant events in patients with rheumatoid arthritis and up to 4.5 years of exposure | 3 |
| 14 | Longer-term safety of fostamatinib (R788) in patients with rheumatoid arthritis. Analysis of clinical trial data from up to 2 years of exposure | 7 |
| 15 | Magnetic resonance imaging assessments of patients with RA and their association with clinical and radiographic outcomes | 1 |
| 16 | Assessment of inflammation and damage by MRI in established RA patients with Methotrexate inadequate response receiving Golimumab: Results of the GO-FORWARD trial | 2 |
| 17 | GOLIMUMAB AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: RESULTS OF GO-BEFORE AND GO-FORWARD STUDIES | 1 |
| 18 | 24 | |
| 19 | Safety Of Combination Therapy With Anakinra And Etanercept In Patients With Rheumatoid Arthritis. | 23 |
| 20 | Primary care rheumatology | 10 |
About Mark C. Genovese
Mark C. Genovese is a scholar working on Rheumatology, Genetics and Hematology, having authored 317 papers that have together received 22.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (210 papers), Chronic Lymphocytic Leukemia Research (112 papers) and Autoimmune and Inflammatory Disorders Research (88 papers). The work is most often cited by research in Rheumatology (14.1k citations), Hematology (6.5k citations) and Immunology (8.5k citations). Mark C. Genovese has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Edward Keystone, Roy Fleischmann, Larry W. Moreland, Michael Schiff, Stanley Cohen, Joan M. Bathon, Eric J. Kunkel, Eugene C. Butcher, Maxime Dougados and Richard W. Martin. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.